Cargando…

Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats

Alpha7 nicotinic acetylcholine receptors (nAChRs) play an important role in learning and memory and are promising targets for pharmacological cognitive enhancement. Memantine, an approved substance for Alzheimer’s disease treatment, is an antagonist of the N-Methyl-D-aspartate receptor (NMDAR) and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bali, Zsolt Kristóf, Bruszt, Nóra, Tadepalli, Sai Ambika, Csurgyók, Roland, Nagy, Lili Veronika, Tompa, Márton, Hernádi, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371842/
https://www.ncbi.nlm.nih.gov/pubmed/30804787
http://dx.doi.org/10.3389/fphar.2019.00073
_version_ 1783394642338775040
author Bali, Zsolt Kristóf
Bruszt, Nóra
Tadepalli, Sai Ambika
Csurgyók, Roland
Nagy, Lili Veronika
Tompa, Márton
Hernádi, István
author_facet Bali, Zsolt Kristóf
Bruszt, Nóra
Tadepalli, Sai Ambika
Csurgyók, Roland
Nagy, Lili Veronika
Tompa, Márton
Hernádi, István
author_sort Bali, Zsolt Kristóf
collection PubMed
description Alpha7 nicotinic acetylcholine receptors (nAChRs) play an important role in learning and memory and are promising targets for pharmacological cognitive enhancement. Memantine, an approved substance for Alzheimer’s disease treatment, is an antagonist of the N-Methyl-D-aspartate receptor (NMDAR) and also acts as an alpha7 nAChR antagonist. Here, we tested the interaction between an alpha7 nAChR agonist (PHA-543613) and memantine. Efficacy of memantine, PHA-543613, and their co-administration were investigated on the spatial working memory of rats using the spontaneous alternation paradigm in T-maze. Scopolamine-induced transient amnesia was used to model cognitive impairment. First, the dose-response relationship was assessed for memantine, and its lowest effective dose was found to be 0.1 mg/kg. Then, co-administration treatments with subeffective doses of the alpha7 nAChR agonist PHA-543613 and different doses of memantine were tested. The co-administration of subeffective drug doses significantly improved memory performance of the rats and reversed scopolamine-induced deficits. Interestingly, a higher than effective (0.3 mg/kg) dose of memantine did not increase performance in monotreatment, only in co-administration with PHA-543613. However, the co-administration of PHA-543613 did not further increase the efficacy of the previously effective monotreatment doses of memantine. Thus, the efficacy of memantine monotreatment and its co-administration with PHA-543613 converged to create a common ceiling effect, with an additive interaction found in the behavioral effects. These results suggest that memantine and PHA-543613 may exert their cognitive enhancer effects on the same target, possibly on the alpha7 nAChRs. Results also suggest possible benefits of a combination therapy with memantine and alpha7 nAChR agonists.
format Online
Article
Text
id pubmed-6371842
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63718422019-02-25 Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats Bali, Zsolt Kristóf Bruszt, Nóra Tadepalli, Sai Ambika Csurgyók, Roland Nagy, Lili Veronika Tompa, Márton Hernádi, István Front Pharmacol Pharmacology Alpha7 nicotinic acetylcholine receptors (nAChRs) play an important role in learning and memory and are promising targets for pharmacological cognitive enhancement. Memantine, an approved substance for Alzheimer’s disease treatment, is an antagonist of the N-Methyl-D-aspartate receptor (NMDAR) and also acts as an alpha7 nAChR antagonist. Here, we tested the interaction between an alpha7 nAChR agonist (PHA-543613) and memantine. Efficacy of memantine, PHA-543613, and their co-administration were investigated on the spatial working memory of rats using the spontaneous alternation paradigm in T-maze. Scopolamine-induced transient amnesia was used to model cognitive impairment. First, the dose-response relationship was assessed for memantine, and its lowest effective dose was found to be 0.1 mg/kg. Then, co-administration treatments with subeffective doses of the alpha7 nAChR agonist PHA-543613 and different doses of memantine were tested. The co-administration of subeffective drug doses significantly improved memory performance of the rats and reversed scopolamine-induced deficits. Interestingly, a higher than effective (0.3 mg/kg) dose of memantine did not increase performance in monotreatment, only in co-administration with PHA-543613. However, the co-administration of PHA-543613 did not further increase the efficacy of the previously effective monotreatment doses of memantine. Thus, the efficacy of memantine monotreatment and its co-administration with PHA-543613 converged to create a common ceiling effect, with an additive interaction found in the behavioral effects. These results suggest that memantine and PHA-543613 may exert their cognitive enhancer effects on the same target, possibly on the alpha7 nAChRs. Results also suggest possible benefits of a combination therapy with memantine and alpha7 nAChR agonists. Frontiers Media S.A. 2019-02-05 /pmc/articles/PMC6371842/ /pubmed/30804787 http://dx.doi.org/10.3389/fphar.2019.00073 Text en Copyright © 2019 Bali, Bruszt, Tadepalli, Csurgyók, Nagy, Tompa and Hernádi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bali, Zsolt Kristóf
Bruszt, Nóra
Tadepalli, Sai Ambika
Csurgyók, Roland
Nagy, Lili Veronika
Tompa, Márton
Hernádi, István
Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title_full Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title_fullStr Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title_full_unstemmed Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title_short Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
title_sort cognitive enhancer effects of low memantine doses are facilitated by an alpha7 nicotinic acetylcholine receptor agonist in scopolamine-induced amnesia in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371842/
https://www.ncbi.nlm.nih.gov/pubmed/30804787
http://dx.doi.org/10.3389/fphar.2019.00073
work_keys_str_mv AT balizsoltkristof cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT brusztnora cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT tadepallisaiambika cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT csurgyokroland cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT nagyliliveronika cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT tompamarton cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats
AT hernadiistvan cognitiveenhancereffectsoflowmemantinedosesarefacilitatedbyanalpha7nicotinicacetylcholinereceptoragonistinscopolamineinducedamnesiainrats